FDA — authorised 13 June 1980
- Marketing authorisation holder: LILLY
- Status: approved
🇺🇸 Cinobac in United States
FDA authorised Cinobac on 13 June 1980
Marketing authorisations
FDA — authorised 13 June 1980
- Application: NDA018067
- Marketing authorisation holder: LILLY
- Local brand name: CINOBAC
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 28 February 1992
- Application: ANDA073005
- Marketing authorisation holder: TEVA
- Local brand name: CINOXACIN
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 28 February 1992
- Application: ANDA073006
- Marketing authorisation holder: TEVA
- Local brand name: CINOXACIN
- Indication: CAPSULE — ORAL
- Status: approved
Cinobac in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Cinobac approved in United States?
Yes. FDA authorised it on 13 June 1980; FDA authorised it on 13 June 1980; FDA authorised it on 28 February 1992.
Who is the marketing authorisation holder for Cinobac in United States?
LILLY holds the US marketing authorisation.